Go Deep
Medicamen Organics Limited
Medicamen Organics Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 17,916 | -7.2 | 4.13 | 0.51 | 24.70 |
| Oct 2026 | 21,894 | -7.2 | 0.95 | 0.50 | 23.35 |
Medicamen Organics Limited Quarterly Results
Quarterly data isn't available for this company right now.
Medicamen Organics Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 226,303,000.0 | 381,877,000.0 | 252,717,000.0 | 221,471,000.0 | — |
| Net Profit | -40,194,000.0 | 40,471,000.0 | 26,243,000.0 | 9,693,000.0 | — |
| EPS | — | 3.7 | 2.2 | 0.8 | 0.1 |
Medicamen Organics Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 516,288,000.0 | 592,074,000.0 | 384,401,000.0 | 325,857,000.0 | — |
| Total Liabilities | 230,423,000.0 | 287,268,000.0 | 231,807,000.0 | 236,058,000.0 | — |
| Total Equity | 287,273,000.0 | 301,292,000.0 | 152,594,000.0 | 89,799,000.0 | — |
Owes vs Owns
Medicamen Organics Limited owed ₹0.45 for every ₹1 it owned in Mar 2026, down from ₹0.72 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.45× | 0.49× | 0.60× | 0.72× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Medicamen Organics Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 2.5%Receivables 36.1%Inventory 20.4%Fixed assets (tangible) 25.0%Intangible assets 1.0%Other assets 15.0%
How it's funded — Mar 2026
Short-term debt 25.7%Long-term debt 2.0%Payables 10.8%Other liabilities 6.2%Shareholders' equity 55.4%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1.3 | 4.1 | 0.6 | 0.5 |
| Receivables | 18.6 | 25.9 | 16.7 | 10.8 |
| Inventory | 10.5 | 7.5 | 6.1 | 6.1 |
| Fixed assets (tangible) | 12.9 | 12.3 | 10.5 | 10.9 |
| Intangible assets | 0.5 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 7.7 | 9.4 | 4.5 | 4.3 |
| Liabilities & equity | ||||
| Short-term debt | 13.2 | 12.2 | 12.5 | 11.5 |
| Long-term debt | 1.0 | 0.2 | 0.2 | 0.3 |
| Payables | 5.6 | 11.7 | 7.1 | 9.0 |
| Other liabilities | 3.2 | 4.7 | 3.4 | 2.8 |
| Shareholders' equity | 28.6 | 30.5 | 15.3 | 9.0 |
| Net tangible assets | 28.2 | 30.1 | 15.2 | 9.0 |
Medicamen Organics Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -45,953,000.0 | -45,431,000.0 | -36,620,000.0 | -5,837,000.0 | — |
| Investing Activities | -17,159,000.0 | -23,525,000.0 | -3,372,000.0 | -2,813,000.0 | — |
| Financing Activities | 34,840,000.0 | 104,730,000.0 | 40,142,000.0 | 9,369,000.0 | — |